Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 3,241 - 3,260 results of 21,342 for search '(( significantly ((larger decrease) OR (a decrease)) ) OR ( significant decrease decrease ))', query time: 0.43s Refine Results
  1. 3241
    Evaluation of mitochondrial protein expression and morphology in NMIIC KO mice.

    Evaluation of mitochondrial protein expression and morphology in NMIIC KO mice. by Hiroki Hamaguchi (22783780)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 3242
    Proliferation and differentiation of myoblasts derived from satellite cells in WT and NMIIC KO mice.

    Proliferation and differentiation of myoblasts derived from satellite cells in WT and NMIIC KO mice. by Hiroki Hamaguchi (22783780)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3243
    Expression profile of WRKY-TFs and ROS accumulation in susceptible T200 and tolerant TME3 cassava genotypes.

    Expression profile of WRKY-TFs and ROS accumulation in susceptible T200 and tolerant TME3 cassava genotypes. by Bulelani L. Sizani (21485746)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 3244
    Phenotypic characterization of NMIIC knockout (KO) mice.

    Phenotypic characterization of NMIIC knockout (KO) mice. by Hiroki Hamaguchi (22783780)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 3245
    Hypothetical model of the molecular mechanism underlying the ability of SACMV to suppress the host RNA silencing mechanism (PTGS) and systemic acquired resistance (SAR).

    Hypothetical model of the molecular mechanism underlying the ability of SACMV to suppress the host RNA silencing mechanism (PTGS) and systemic acquired resistance (SAR). by Bulelani L. Sizani (21485746)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 3246
    Reinforced sample destruction mode.

    Reinforced sample destruction mode. by Xiaoyan Ding (291429)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 3247
    One-dimensional sand column test conditions.

    One-dimensional sand column test conditions. by Xiaoyan Ding (291429)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 3248
    Total count of HiFi reads indicating gene variation in 24 cassava genotypes.

    Total count of HiFi reads indicating gene variation in 24 cassava genotypes. by Bulelani L. Sizani (21485746)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 3249
    COVID19 effect on essential services.

    COVID19 effect on essential services. by Admas Abera (11821659)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 3250
    Fiber types and muscle force in the soleus of 18-20-week-old WT and NMIIC KO mice.

    Fiber types and muscle force in the soleus of 18-20-week-old WT and NMIIC KO mice. by Hiroki Hamaguchi (22783780)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 3251
    Phenotypic characterization of 81-week-old NMIIC KO mice.

    Phenotypic characterization of 81-week-old NMIIC KO mice. by Hiroki Hamaguchi (22783780)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 3252
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  13. 3253
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  14. 3254
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  15. 3255
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  16. 3256
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  17. 3257
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  18. 3258
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  19. 3259
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  20. 3260
    Experimental flow chart.

    Experimental flow chart. by Dong Feng (5375471)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: